Saint-Prex, Switzerland

Bo-Eric Persson

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Ferring International Center Sa.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bo-Eric Persson. Retrieved from https://idiyas.com/inventor/bo-eric-persson-wdce75wx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bo-Eric Persson: Innovator in Prostate Cancer Treatment

Introduction

Bo-Eric Persson is a notable inventor based in Saint-Prex, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of metastatic stage prostate cancer. His innovative approach has the potential to improve the lives of many patients facing this challenging condition.

Latest Patents

Bo-Eric Persson holds a patent for "Methods for treating metastatic stage prostate cancer." This invention provides methods and dosing regimens for treating metastatic stage prostate cancer in a subject using degarelix. It also includes related methods of using degarelix in a subject identified as having metastatic stage prostate cancer, as well as methods of using degarelix to prevent or delay the progression of locally advanced prostate cancer. He has 1 patent to his name.

Career Highlights

Throughout his career, Bo-Eric Persson has been associated with Ferring International Center SA, where he has focused on developing innovative treatments for various medical conditions. His work has been instrumental in advancing therapeutic options for patients suffering from prostate cancer.

Conclusion

Bo-Eric Persson's contributions to the field of medicine, particularly in prostate cancer treatment, highlight his dedication to improving patient outcomes. His innovative methods and ongoing work continue to pave the way for advancements in cancer therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…